The role of hepatic lipid composition in obesity‐related metabolic disease-Reference-Cited by-同舟云学术

The role of hepatic lipid composition in obesity‐related metabolic disease

Published:2021-09-27 Issue:12 Volume:41 Page:2819-2835
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Willis Scott A.¹²^ORCID,Bawden Stephen J.³⁴,Malaikah Sundus¹²⁵,Sargeant Jack A.²⁶^ORCID,Stensel David J.¹²,Aithal Guruprasad P.⁴⁷^ORCID,King James A.¹²^ORCID

Affiliation:

1. National Centre for Sport and Exercise Medicine School of Sport, Exercise and Health Sciences Loughborough University Loughborough UK

2. NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust and University of Leicester Leicester UK

3. Sir Peter Mansfield Imaging Centre University of Nottingham Nottingham UK

4. NIHR Nottingham Biomedical Research Centre Nottingham University Hospitals NHS Trust and the University of Nottingham Leicester UK

5. Faculty of Applied Medical Sciences King Abdulaziz University Jeddah Saudi Arabia

6. Diabetes Research Centre University of Leicester Leicester UK

7. Nottingham Digestive Diseases Centre School of Medicine University of Nottingham Nottingham UK

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15059

Reference150 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012

4. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

5. Mechanisms, Pathophysiology, and Management of Obesity

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety evaluation of Avicenna germinans leaf extracts in rats;Phytomedicine Plus;2024-11

2. Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity;Clinics and Research in Hepatology and Gastroenterology;2024-08

3. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction‐associated steatotic liver disease;The Journal of Pathology;2024-07-18

4. Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training;Diabetes, Obesity and Metabolism;2024-07-08

5. A Cross-Sectional Pilot Study on Association of Ready-to-Eat and Processed Food Intakes with Metabolic Factors, Serum Trans Fat and Phospholipid Fatty Acid Compositions in Healthy Japanese Adults;Nutrients;2024-04-02